Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction

摘要

Aims Vitamin D deficiency is prevalent in heart failure (HF), but its relevance in early stages of heart failure with preserved ejection fraction (HFpEF) is unknown. We tested the association of 25‐hydroxyvitamin D [25(OH)D] serum levels with mortality, hospitalizations, cardiovascular risk factors, and echocardiographic parameters in patients with asymptomatic diastolic dysfunction (DD) or newly diagnosed HFpEF. Methods and results We measured 25(OH)D serum levels in outpatients with risk factors for DD or history of HF derived from the DIAST‐CHF study. Participants were comprehensively phenotyped including physical examination, echocardiography, and 6?min walk test and were followed up to 5 years. Quality of life was evaluated by the Short Form 36 (SF‐36) questionnaire. We included 787 patients with available 25(OH)D levels. Median 25(OH)D levels were 13.1?ng/mL, mean E/e′ medial was 13.2, and mean left ventricular ejection fraction was 59.1%. Only 9% ( n ?=?73) showed a left ventricular ejection fraction 50%. Fifteen per cent ( n ?=?119) of the recruited participants had symptomatic HFpEF. At baseline, participants with 25(OH)D levels in the lowest tertile (≤10.9?ng/L; n ?=?263) were older, more often symptomatic (oedema and fatigue, all P ?≤?0.002) and had worse cardiac [higher N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) and left atrial volume index, both P ?≤?0.023], renal (lower glomerular filtration rate, P ?=?0.012), metabolic (higher uric acid levels, P ??0.001), and functional (reduced exercise capacity, 6?min walk distance, and SF‐36 physical functioning score, all P ??0.001) parameters. Increased NT‐proBNP, uric acid, and left atrial volume index and decreased SF‐36 physical functioning scores were independently associated with lower 25(OH)D levels. There was a higher risk for lower 25(OH)D levels in association with HF, DD, and atrial fibrillation (all P ?≤?0.004), which remained significant after adjusting for age. Lower 25(OH)D levels (per 10?ng/mL decrease) tended to be associated with higher 5?year mortality, P ?=?0.05, hazard ratio (HR) 1.55 [1.00; 2.42]. Furthermore, lower 25(OH)D levels (per 10?ng/mL decrease) were related to an increased rate of cardiovascular hospitalizations, P ?=?0.023, HR?=?1.74 [1.08; 2.80], and remained significant after adjusting for age, P ?=?0.046, HR?=?1.63 [1.01; 2.64], baseline NT‐proBNP, P ?=?0.048, HR?=?1.62 [1.01; 2.61], and other selected baseline characteristics and co‐morbidities, P ?=?0.043, HR?=?3.60 [1.04; 12.43]. Conclusions Lower 25(OH)D levels were associated with reduced functional capacity in patients with DD or HFpEF and were significantly predictive for an increased rate of cardiovascular hospitalizations, also after adjusting for age, NT‐proBNP, and selected baseline characteristics and co‐morbidities.